Table 2 Results of univariate Cox analysis and LASSO analysis.

From: Bioinformatics construction and experimental validation of a cuproptosis-related lncRNA prognostic model in lung adenocarcinoma for immunotherapy response prediction

LncRNA ID

Coefficient

HR

HR.95 L

HR.95H

p

AL121935.2

NA

0.199

0.076

0.524

0.001

LINC00592

NA

1.729

1.198

2.495

0.003

TSPOAP1-AS1

NA

0.547

0.362

0.829

0.004

AL606834.1

0.282428620063832

1.446

1.099

1.901

0.008

AC018647.1

NA

0.134

0.029

0.612

0.009

AL138778.1

− 1.30027751298876

0.131

0.039

0.447

0.001

MIR223HG

NA

0.631

0.457

0.869

0.004

AL121933.2

NA

0.758

0.618

0.930

0.008

AP000302.1

− 0.912345907878674

0.215

0.075

0.615

0.004

AC007384.1

− 0.325560951666235

0.518

0.339

0.791

0.002

AL161431.1

0.164875028131049

1.309

1.144

1.498

<0.001

TMPO-AS1

0.337166622358203

1.667

1.211

2.295

0.002

KIAA1671-AS1

− 0.271262462650279

0.627

0.448

0.878

0.007

AC087854.1

NA

0.338

0.158

0.725

0.005

  1. Bold biomarker: lncRNAs used for prognostic signature construction; HR. 95 L: hazard ratio 95% low limit; HR. 95 H: hazard ratio 95% high limit; NA: not avaliable.
Back to article page